Navigation Links
NIH funds research center for women's reproductive health at Einstein

March 20, 2009 (BRONX, NY) The National Institute of Child Health and Development (NICHD) of the National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a $7.5 million grant to establish a Specialized Cooperative Center Program in Reproduction and Infertility Research (SCCPIR).One of only 13 such centers in the country and the only one in New York State, the new center will focus on a wide range of diseases of the female reproductive tract, including menstrual disorders, endometriosis, and infertility.

"The grant will allow us to launch new studies of reproductive biology and to position Einstein as the focus of such studies for the entire state," says Jeffrey W. Pollard, Ph.D., professor of developmental and molecular biology and of obstetrics & gynecology and women's health, who will be leading the new center.

Created in 1997, the SCCPIR program promotes interactions among basic and clinical scientists. The goal is to translate breakthroughs in fundamental understanding of key reproductive processes into clinical practice, and promptly address in the laboratory questions that arise in the clinic. The centers also serve as national resources for training and developing the careers of new scientists who choose to pursue research in high priority areas of reproduction and infertility research.

Einstein's SCCPIR will concentrate on basic studies of endometrial biology and reproductive neuroendocrinology, with a particular emphasis on the reproductive health needs of the local Bronx community. (A complete list of the studies appears below.) "Research in reproductive biology has profoundly and positively influenced women's health in the last few decades," says Dr. Pollard. "More recently, the new technologies have enabled us to make great strides in understanding the basic biology of fertility and reproduction in animal models. This funding will help us determine whether the same biochemical pathways that we've identified in rodents are also operative in humans and then apply those findings to clinical practice."

"Our studies will have implications for the health of women in general. But we are particularly concerned with reproductive health in the Bronx, and this center will continue a profound partnership between Einstein and Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein," adds Dr. Pollard. "Obesity, diabetes, and metabolic syndrome are especially common here in the local community. Each of these conditions is strongly associated with reproductive tract diseases particularly infertility, endometriosis, and endometrial cancer."

Endometriosis, the abnormal growth of endometrial tissue outside the uterus, is one of the most common gynecological diseases, affecting more than 5.5 million women in North America. According to the NICHD, an estimated 2 to 10 percent of women of reproductive age have endometriosis. The two most common symptoms of the disease are pain and infertility. About 30 to 40 percent of women with endometriosis are infertile. In 2008, 40,100 women in the U.S. were diagnosed with endometrial cancer, another disease of abnormal cell growth in the endometrium, and 7,470 died of the disease, according to the National Cancer Institute.

"We are delighted to establish a SCCPIR at Einstein," adds Nanette Santoro, M.D., professor of obstetrics & gynecology and women's health. "The grant is highly competitive and this was the last year in which new sites could be added. In addition to having funds for our own research, the grant allows us to interact with the other SCCPIR sites nationwide and conduct collaborative studies relevant to our areas of interest."

Research Projects and Principal Investigators at Einstein's Specialized Cooperative Center Program in Reproduction and Infertility Research

  • "Estrogen and Progesterone Regulation of Human Endometrial Cell Proliferation"Drs. Pollard and Santoro.
  • "Reproductive Hormonal Alterations in Obesity"Dr. Santoro, Maureen Charron, Ph.D., professor of biochemistry, of obstetrics & gynecology and women's health, and of medicine; and Alex Polotsky, M.D., assistant professor of obstetrics & gynecology and women's health.
  • "IGF-I and Neuroendocrine Regulation of Female Reproductive Function"Anne Etgen, Ph.D., professor of neuroscience, of psychiatry and behavioral sciences, and of pediatrics; and Genevieve Neal-Perry, M.D., Ph.D., assistant professor of obstetrics & gynecology and women's health and of neuroscience.
  • "Antagonistic actions of melanocortins and leptin on reproductive competence"Streamson Chua, Jr., M.D., Ph.D., professor of medicine and of neuroscience.


Contact: Deirdre Branley
Albert Einstein College of Medicine

Related biology news :

1. Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism
2. F-MARC funds more soccer and health research
3. More freedom to take risks: DFG funds the first Reinhart Koselleck Projects
4. NIH funds 16 Science Education Partnership Awards
5. NSF funds research at Illinois on sustainable biofuels infrastructure
6. NIAID funds studies of how SARS and bird flu evade antiviral responses
7. Human Microbiome Project awards funds for technology development, data analysis and ethical research
8. NSF funds new Center for the Physics of Living Cells at Illinois
9. NSF funds multi-university center to study environmental implications of nanotechnology
10. NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells
11. EPA funds ground-breaking Lyme disease research
Post Your Comments:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology: